Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 264

1.

Comparative study of enema retention and preference in ulcerative colitis.

Ingram JR, Rhodes J, Evans BK, Newcombe RG, Thomas GA.

Postgrad Med J. 2005 Sep;81(959):594-8.

PMID:
16143691
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A randomized trial of nicotine enemas for active ulcerative colitis.

Ingram JR, Thomas GA, Rhodes J, Green JT, Hawkes ND, Swift JL, Srivastava ED, Evans BK, Williams GT, Newcombe RG, Courtney E, Pillai S.

Clin Gastroenterol Hepatol. 2005 Nov;3(11):1107-14.

PMID:
16271342
[PubMed - indexed for MEDLINE]
3.

Pharmacokinetics of nicotine carbomer enemas: a new treatment modality for ulcerative colitis.

Green JT, Thomas GA, Rhodes J, Evans BK, Russell MA, Feyerabend C, Fuller GS, Newcombe RG, Sandborn WJ.

Clin Pharmacol Ther. 1997 Mar;61(3):340-8.

PMID:
9084459
[PubMed - indexed for MEDLINE]
4.

Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicenter comparative trial with 5-ASA enema.

Campieri M, Paoluzi P, D'Albasio G, Brunetti G, Pera A, Barbara L.

Dig Dis Sci. 1993 Oct;38(10):1843-50.

PMID:
8404405
[PubMed - indexed for MEDLINE]
5.

Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study.

Sandborn WJ, Tremaine WJ, Leighton JA, Lawson GM, Zins BJ, Compton RF, Mays DC, Lipsky JJ, Batts KP, Offord KP, Hurt RD, Green J.

Aliment Pharmacol Ther. 1997 Aug;11(4):663-71.

PMID:
9305473
[PubMed - indexed for MEDLINE]
7.

Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis.

Campieri M, Corbelli C, Gionchetti P, Brignola C, Belluzzi A, Di Febo G, Zagni P, Brunetti G, Miglioli M, Barbara L.

Dig Dis Sci. 1992 Dec;37(12):1890-7.

PMID:
1473437
[PubMed - indexed for MEDLINE]
8.

5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: long-term results.

Guarino J, Chatzinoff M, Berk T, Friedman LS.

Am J Gastroenterol. 1987 Aug;82(8):732-7.

PMID:
3496786
[PubMed - indexed for MEDLINE]
9.

Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis.

Cortot A, Maetz D, Degoutte E, Delette O, Meunier P, Tan G, Cazals JB, Dewit O, Hebuterne X, Beorchia S, Grunberg B, Leprince E, D'Haens G, Forestier S, Idier I, Lémann M.

Am J Gastroenterol. 2008 Dec;103(12):3106-14. doi: 10.1111/j.1572-0241.2008.02152.x.

PMID:
19086960
[PubMed - indexed for MEDLINE]
10.

Nicotine enemas for active ulcerative colitis--a pilot study.

Green JT, Thomas GA, Rhodes J, Williams GT, Evans BK, Russell MA, Feyerabend C, Rhodes P, Sandborn WJ.

Aliment Pharmacol Ther. 1997 Oct;11(5):859-63.

PMID:
9354193
[PubMed - indexed for MEDLINE]
11.

Effect of weekend 5-aminosalicylic acid (mesalazine) enema as maintenance therapy for ulcerative colitis: results from a randomized controlled study.

Yokoyama H, Takagi S, Kuriyama S, Takahashi S, Takahashi H, Iwabuchi M, Takahashi S, Kinouchi Y, Hiwatashi N, Tsuji I, Shimosegawa T.

Inflamm Bowel Dis. 2007 Sep;13(9):1115-20.

PMID:
17455207
[PubMed - indexed for MEDLINE]
12.

Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis.

Gross V, Bar-Meir S, Lavy A, Mickisch O, Tulassay Z, Pronai L, Kupcinskas L, Kiudelis G, Pokrotnieks J, Kovács A, Faszczyk M, Razbadauskas A, Margus B, Stolte M, Müller R, Greinwald R; International Budesonide Foam Study Group.

Aliment Pharmacol Ther. 2006 Jan 15;23(2):303-12.

PMID:
16393311
[PubMed - indexed for MEDLINE]
Free Article
13.

Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine.

Ingram JR, Routledge P, Rhodes J, Marshall RW, Buss DC, Evans BK, Feyerabend C, Thomas GA.

Aliment Pharmacol Ther. 2004 Oct 15;20(8):859-65.

PMID:
15479357
[PubMed - indexed for MEDLINE]
Free Article
14.

Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis.

Hammond A, Andus T, Gierend M, Ecker KW, Scholmerich J, Herfarth H; German Budesonide Foam Study Group.

Hepatogastroenterology. 2004 Sep-Oct;51(59):1345-9.

PMID:
15362749
[PubMed - indexed for MEDLINE]
15.

Scintigraphic imaging and absorption of a 5-aminosalicylic acid enema in patients with ileorectal anastomosis.

Lisciandrano D, Benti R, Ranzi T, Baldassarri AR, Bruno A, Bianchi PA, Gerundini P.

J Nucl Med. 1999 Oct;40(10):1630-6.

PMID:
10520702
[PubMed - indexed for MEDLINE]
Free Article
16.

Quantitative distribution of radiolabeled 5-aminosalicylic acid enemas in patients with left-sided ulcerative colitis.

Vitti RA, Meyers F, Knight LC, Siegel JA, Malmud LS, Fisher RS.

Dig Dis Sci. 1989 Nov;34(11):1792-7.

PMID:
2582990
[PubMed - indexed for MEDLINE]
17.

Plasma fibrinogen in ulcerative colitis: the effect of disease activity and nicotine therapy in a randomised controlled trial.

Ingram JR, Rhodes J, Collins PW, Williams GT, Newcombe RG, Thomas GA.

Dig Liver Dis. 2005 Nov;37(11):832-7. Epub 2005 Sep 15.

PMID:
16169302
[PubMed - indexed for MEDLINE]
18.

A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis.

Danielsson A, Hellers G, Lyrenäs E, Löfberg R, Nilsson A, Olsson O, Olsson SA, Persson T, Salde L, Naesdal J, et al.

Scand J Gastroenterol. 1987 Oct;22(8):987-92.

PMID:
3317784
[PubMed - indexed for MEDLINE]
19.

Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.

Biancone L, Gionchetti P, Blanco Gdel V, Orlando A, Annese V, Papi C, Sostegni R, D'Incà R, Petruzziello C, Casa A, Sica G, Calabrese E, Campieri M, Pallone F.

Dig Liver Dis. 2007 Apr;39(4):329-37. Epub 2007 Mar 7.

PMID:
17347061
[PubMed - indexed for MEDLINE]
20.

Treatment of active distal ulcerative colitis with immunoglobulin G enemas.

Jarløv AE, Munkholm P, Schmidt PN, Langholz E, Vestergaard BF, Bech RM.

Aliment Pharmacol Ther. 1993 Oct;7(5):561-5.

PMID:
8280825
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk